Stay updated with breaking news from Authorization Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SKYCLARYS® Approved by FDA in the U.S. Approximately 500 Patient Start Forms Received for SKYCLARYS Marketing Authorization Application for Omaveloxolone in Europe Under Review Announced... | May 10, 2023
/PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered in Italy, today announced that it has partnered with Avanzanite Bioscience...
SIFI Announces License Agreement With Avanzanite Bioscience for Akantior® - read this article along with other careers information, tips and advice on BioSpace
Operator: Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2022 Financial Results and Business Update Call.
Ebvallo™ is the first authorised allogeneic T-cell immunotherapy and has been approved for EU patients with relapsed or refractory EBV+ PTLD.